169 related articles for article (PubMed ID: 11861289)
1. Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells.
Vitale M; Zimmer J; Castriconi R; Hanau D; Donato L; Bottino C; Moretta L; de la Salle H; Moretta A
Blood; 2002 Mar; 99(5):1723-9. PubMed ID: 11861289
[TBL] [Abstract][Full Text] [Related]
2. The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients.
Markel G; Mussaffi H; Ling KL; Salio M; Gadola S; Steuer G; Blau H; Achdout H; de Miguel M; Gonen-Gross T; Hanna J; Arnon TI; Qimron U; Volovitz I; Eisenbach L; Blumberg RS; Porgador A; Cerundolo V; Mandelboim O
Blood; 2004 Mar; 103(5):1770-8. PubMed ID: 14604968
[TBL] [Abstract][Full Text] [Related]
3. Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome).
Zimmer J; Donato L; Hanau D; Cazenave JP; Tongio MM; Moretta A; de la Salle H
J Exp Med; 1998 Jan; 187(1):117-22. PubMed ID: 9419217
[TBL] [Abstract][Full Text] [Related]
4. Molecular studies and NK cell function of a new case of TAP2 homozygous human deficiency.
Matamoros N; Milà J; Llano M; Balas A; Vicario JL; Pons J; Crespí C; Martinez N; Iglesias-Alzueta J; López-Botet M
Clin Exp Immunol; 2001 Aug; 125(2):274-82. PubMed ID: 11529920
[TBL] [Abstract][Full Text] [Related]
5. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.
Moretta A; Bottino C; Vitale M; Pende D; Cantoni C; Mingari MC; Biassoni R; Moretta L
Annu Rev Immunol; 2001; 19():197-223. PubMed ID: 11244035
[TBL] [Abstract][Full Text] [Related]
6. Independent contributions of HLA epitopes and killer inhibitory receptor expression to the functional alloreactive specificity of natural killer cells.
Young NT; Rust NA; Dallman MJ; Cerundolo V; Morris PJ; Welsh KI
Hum Immunol; 1998 Nov; 59(11):700-12. PubMed ID: 9796738
[TBL] [Abstract][Full Text] [Related]
7. Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell lines.
Sivori S; Parolini S; Marcenaro E; Millo R; Bottino C; Moretta A
Hum Immunol; 2000 Nov; 61(11):1055-8. PubMed ID: 11137207
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
[TBL] [Abstract][Full Text] [Related]
9. HCMV glycoprotein US6 mediated inhibition of TAP does not affect HLA-E dependent protection of K-562 cells from NK cell lysis.
Ulbrecht M; Hofmeister V; Yüksekdag G; Ellwart JW; Hengel H; Momburg F; Martinozzi S; Reboul M; Pla M; Weiss EH
Hum Immunol; 2003 Feb; 64(2):231-7. PubMed ID: 12559625
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells.
Nattermann J; Nischalke HD; Hofmeister V; Kupfer B; Ahlenstiel G; Feldmann G; Rockstroh J; Weiss EH; Sauerbruch T; Spengler U
Antivir Ther; 2005; 10(1):95-107. PubMed ID: 15751767
[TBL] [Abstract][Full Text] [Related]
11. Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production.
Mingari MC; Vitale C; Cambiaggi A; Schiavetti F; Melioli G; Ferrini S; Poggi A
Int Immunol; 1995 Apr; 7(4):697-703. PubMed ID: 7547697
[TBL] [Abstract][Full Text] [Related]
12. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
Romagnani C; Pietra G; Falco M; Mazzarino P; Moretta L; Mingari MC
Hum Immunol; 2004 May; 65(5):437-45. PubMed ID: 15172443
[TBL] [Abstract][Full Text] [Related]
13. HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells.
Carbone E; Neri P; Mesuraca M; Fulciniti MT; Otsuki T; Pende D; Groh V; Spies T; Pollio G; Cosman D; Catalano L; Tassone P; Rotoli B; Venuta S
Blood; 2005 Jan; 105(1):251-8. PubMed ID: 15328155
[TBL] [Abstract][Full Text] [Related]
14. General role of HLA class I molecules in the protection of target cells from lysis by natural killer cells: evidence that the free heavy chains of class I molecules are not sufficient to mediate the protective effect.
Ciccone E; Pende D; Nanni L; Di Donato C; Viale O; Beretta A; Vitale M; Sivori S; Moretta A; Moretta L
Int Immunol; 1995 Mar; 7(3):393-400. PubMed ID: 7794819
[TBL] [Abstract][Full Text] [Related]
15. Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells.
Falk CS; Steinle A; Schendel DJ
J Exp Med; 1995 Oct; 182(4):1005-18. PubMed ID: 7561674
[TBL] [Abstract][Full Text] [Related]
16. Cutting edge: HLA-E binds a peptide derived from the ATP-binding cassette transporter multidrug resistance-associated protein 7 and inhibits NK cell-mediated lysis.
Wooden SL; Kalb SR; Cotter RJ; Soloski MJ
J Immunol; 2005 Aug; 175(3):1383-7. PubMed ID: 16034073
[TBL] [Abstract][Full Text] [Related]
17. Tolerance of NK and LAK activity for HLA class I-deficient targets in a TAP1-deficient patient (bare lymphocyte syndrome type I).
Furukawa H; Yabe T; Watanabe K; Miyamoto R; Miki A; Akaza T; Tadokoro K; Tohma S; Inoue T; Yamamoto K; Juji T
Hum Immunol; 1999 Jan; 60(1):32-40. PubMed ID: 9952025
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of the molecular factors controlling Qa1-mediated protection of target cells from NK lysis.
Gays F; Fraser KP; Toomey JA; Diamond AG; Millrain MM; Dyson PJ; Brooks CG
J Immunol; 2001 Feb; 166(3):1601-10. PubMed ID: 11160201
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic activity of natural killer cells lacking killer-inhibitory receptors for self-HLA class I molecules against autologous hematopoietic stem cells in healthy individuals.
Grau R; Lang KS; Wernet D; Lang P; Niethammer D; Pusch CM; Handgretinger R
Exp Mol Pathol; 2004 Apr; 76(2):90-8. PubMed ID: 15010286
[TBL] [Abstract][Full Text] [Related]
20. Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules.
Bonaparte MI; Barker E
Blood; 2004 Oct; 104(7):2087-94. PubMed ID: 15117765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
